3[3]Cortez-Pinto HH, Camilo ME, Baptista AA, et al . Non-alcoholic fatty liver: Another feature of the metabolic syndrome? Clin Nutr,1999, 18(6):353～358
4[4]Sanyal AJ, Campbell Sarget C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 2001,120:1183～1192
5[5]Knobler H, Schattner A, Zhomicki T, et al. Fatty liver-an additional and treatable feature of the insulin resistance syndrome. Q J Med, 1999,92:73～79
6[6]Caldwell SH, Hespenheide EE, Redick JA, et al. A pilot study of a thiazolidinedione, troglitazone in nonalcoholic steatohepatitis. Am J Gastroenterol 2001,96:519～525
7[7]Luyckx FH, Scheen AJ, Lefvre PJ. Non-alcoholic steatohepatitis:association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000,26:98～106
8Fishbein MH, Miner M, Mogren C, et al. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis[J]. J Pediatr Gastroenterol Nutr, 2003, 36(1): 54-61.
9Joost H, Ggiesen K, Kluge R, et al. Insulin resistance and metabolic syndrome[J]. Z Kardiol, 2000, 89: 377 - 382.
10Hauner H. Imulin resistance and the mtabolic syndrom- achallenge of the new millenium[J ]. Eu r J Clin Nutr, 2002, 56: s25 - 29.
